In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Where expertise becomes a community

Who else in the world can bring together healthcare professionals from so many countries and every subspecialty of cardiology in one place?

Now it’s time to belong.

ESC Science In Your Language

Access ESC science and resources available in Spanish

Access science

ESC in Mexico

At the 30th annual congress of the Mexican Society of Cardiology

Add to calendar02/11/20170:00 05/11/20170:00 Europe/Paris ESC in Mexico

This scientific programme is part of the ESC’s Global Scientific Activities - a series of international educational courses in collaboration with cardiology partners all over the world.

Mexican Society of Cardiology true DD/MM/YYYY


This scientific programme is part of the ESC’s Global Scientific Activities - a series of international educational courses in collaboration with cardiology partners all over the world.

In close collaboration with the Mexican Society of Cardiology, the ESC brings highlights in key topics from ESC Congress to Guadalajara as part of the Final Programme of the 30th annual congress of the Mexican Society of Cardiology.


Thursday 2 November

RE Dual PCI and reversal: improving care decisions after coronary revascularisation- Satellite Symposium sponsored by Boehringer Ingelheim


C. Martinez (Mexico)

16:15-16:25 Antithrombotic strategies post PCI: What do we know so far? C. Martinez (Mexico)
16:25-16:45 Dual vs triple antithrombotic therapy: New evidence E. Gaxiola (Mexico)
16:45-17:00 Dabigatrán reversal when the unexpected happens R. Izaguirre (Mexico)
17:00-17:15 Panel discussion  


Friday 3 November

 State of the art in Aortic stenosis and CAD


J. Bax (Netherlands), E. Alexanderson Rosas (Mexico)

08:30-09:30 Guadalajara 1
08:30-08:45 What is new in Aortic stenosis? The recent ESC Guidelines  J. Bax (Netherlands)
08:45-08:50 Discussion
08:50-09:05 STEMI - The new evidence   S. Price (United Kingdom)
09:05-09:10  Discussion  
09:10-09:25  Aortic stenosis treatment in patients with concomitant CAD   S. Trevethan (Mexico)
09:25-09:30  Discussion  

State of the art in HF and anticoagulation


S. Price (United Kingdom), M. Angel Luna Calvo (Mexico)

12:30-13:30 Guadalaraja 3
12:30-12:45 Revisiting Heart Failure. The ESC recommendations P. Ponikowski (Poland)
12:45-12:50 Discussion  
12:50-13:05 Difficult scenarios for anticoagulation in Atrial Fibrillation patients ACO/DAPT  J. Jarasunas (Lithuania)
13:05-13:10 Discussion  
13:10-13:25 Urgent treatment in patients with severe bleeding. Revert or wait? R. Izaguirre (Mexico)
13:25-13:30 Discussion  

Changing Practice : The Role of anticoagulants in vascular disease- Satellite symposium sponsored by Bayer


J. Verdejo-Paris (Mexico)

16:15-16:35 Unmet needs in CAD and PAD? J. Verdejo-Paris (Mexico)
16:35-17:15 Role of Anticoagulants in vascular protection R. C. Welsh (Canada)

Saturday 4 November

Multimodality imaging and prognosis


P. Ponikowski (Poland), P. Gutierrez Fajardo (Mexico)

08:30-09:30 Guadalajara 1
08:30-08:45 Role of echocardiography in disease prognosis P. Nihoyannopoulos (United Kingdom)
08:45-08:50 Discussion  
08:50-09:05 Role of MRI in the prognosis of CV diseases A. Meave (Mexico)
09:05-09:10 Discussion  
09:10-09:25 Role of nuclear medicine in the prognosis of CV diseases C. Guizar (Mexico)                         
09:25-09:30 Discussion  

Difficult decisions


P. Nihoyannopoulos (United Kingdom), M.A Martinez Rios (Mexico)

12:30-13:30 Guadalaraja 3
12:30-12:40   Severe HF with narrow QRS. CRT?  P. Ponikowski (Poland)
12:40-12:45   Discussion  
12:45-12:55  Imaging inside the cath lab. When?  G. A. Llamas Esperon (Mexico)
12:55-13:00  Discussion  
13:00-13:10  Which anticoagulant to use? Antidotes?  J. Jarasunas (Lithuania)
13:10-13:15  Discussion  
13:15-13:25 TAVI in intermediate risk patients G. Eid Lidt (Mexico)
13:25-13:30 Discussion  


Connect with the ESC

Create your My ESC Account – your gateway to the ESC. It’s free and available in a few short clicks! Want regular updates on ESC science, tools and congresses and education? Subscribe to our newsletters.

About the European Society of Cardiology

The ESC is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. It helps more than 95 000 cardiologists expand the boundaries of cardiovascular medicine.

The ESC publishes a dozen different scientific journals, an array of textbooks and world renowned ESC Clinical Practice Guidelines. It provides continuing medical education through webinars and classroom courses, and hosts the summit of cardiovascular science each August - ESC Congress - which attracts more than 30 000 heart specialists and delivers over 4 500 of the latest scientific abstracts.

Join our community of cardiologists from more than 140 countries. Become an ESC PROFESSIONAL MEMBER.

The ESC Global Scientific Activities are supported by Bayer Pharma AG, Boehringer Ingelheim and SERVIER in the form of an unrestricted educational grant.

Bayer AG
Bayer AG